Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan-Dec:25:1076029618823287.
doi: 10.1177/1076029618823287.

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status

Alpesh Amin  1 , W Richey Neuman  2 , Melissa Lingohr-Smith  3 , Brandy Menges  3 , Jay Lin  3
Affiliations

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status

Alpesh Amin et al. Clin Appl Thromb Hemost. 2019 Jan-Dec.

Abstract

The objectives of this study were to examine venous thromboembolism (VTE) prophylaxis patterns and risk for VTE events during hospitalization and in the outpatient continuum of care among patients hospitalized for acute illnesses in the United States with stratification by different age groups and renal disease status. Acutely ill hospitalized patients were identified from the MarketScan databases (January 1, 2012-June 30, 2015) and grouped by age (<65, 65-74, ≥75 years old) and whether or not they had a baseline diagnosis of renal disease, separately. Of acutely ill hospitalized patients, 60.1% (n = 10 748) were <65 years old, 15.7% (n = 2803) were 65 to 74 years old, and 24.3% (n = 4344) were ≥75 years old; 32.9% (n = 5892) had baseline renal disease. Among the study cohorts, the majority of patients received no VTE prophylaxis regardless of age or baseline renal status (52.1%-63.6%). Rates of VTE during hospitalization and in the 6 months postdischarge were 4.7%, 4.6%, and 4.5% for patients <65, 65 to 74, and ≥75 years old, respectively, and 6.3% and 3.8% for patients with and without baseline renal disease. The risk for VTE was elevated for 30 to 40 days after index admission regardless of age and renal disease status.

Keywords: VTE prophylaxis; acute medical illness; elderly; hospitalized patients; inpatient and outpatient continuum of care; renal disease; venous thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Alpesh Amin is a research consultant and/or speaker for Novosys Health, Portola, BI, BMS, and Pfizer. Alpesh Amin did not receive funding for manuscript development. W Richey Neuman was an employee of Portola Pharmaceuticals at the time of this study. Melissa Lingohr-Smith, Brandy Menges, and Jay Lin are employees of Novosys Health, who have received research funds from Portola Pharmaceuticals in connection with conducting this study and development of this manuscript.

Figures

Figure 1.
Figure 1.
Proportions of hospitalized patients who received VTE prophylaxis in the inpatient and outpatient settings with (A) stratification by age-group and (B) stratification by baseline renal disease status. All P values <.001 for comparisons of cohorts stratified by age-group and cohorts stratified by baseline renal disease status. VTE indicates venous thromboembolism.
Figure 2.
Figure 2.
Proportions of patients with VTE events during the index hospitalization and within 6 months of hospital discharge with (A) stratification by age group and (B) stratification by baseline renal disease status. P values are for comparisons of cohorts stratified by age-group and cohorts stratified by baseline renal disease status, separately. VTE indicates venous thromboembolism.
Figure 3.
Figure 3.
Proportions* of VTE-related hospital readmissions in the follow-up period with (A) stratification by age-group and (B) stratification by baseline renal disease status. *These are percentages of all-cause hospital readmissions that were VTE related. P values are for comparisons of cohorts stratified by age-group and cohorts stratified by baseline renal disease status, separately. VTE indicates venous thromboembolism.
Figure 4.
Figure 4.
Risk of VTE events (hazard function) by days after the index hospital admission date of the study population with stratification by age-group and baseline renal disease status. VTE indicates venous thromboembolism.
See this image and copyright information in PMC

References

    1. Heit JA, Crusan DJ, Ashrani AA, Petterson TM, Bailery KR. Effect of a near-universal hospitalization-based prophylaxis regimen on annual number of venous thromboembolism events in the US. Blood. 2017;130(2):109–114. - PMC - PubMed
    1. Mahan CE, Borrego ME, Woersching AL, et al. Venous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost. 2012;108(2):291–302. - PubMed
    1. Cardoso LF, Krokoscz DV, de Paiva EF, et al. Results of a venous thromboembolism prophylaxis program for hospitalized patients. Vasc Health Risk Manag. 2016;12:491–496. - PMC - PubMed
    1. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med. 2004;164(9):963–968. - PubMed
    1. Cohoon KP, Leibson CL, Ransom JE, et al. Costs of venous thromboembolism associated with hospitalization for medical illness. Am J Manag Care. 2015;21(4):e255–e263. - PMC - PubMed